Heba Alkhatabi

519 total citations
43 papers, 311 citations indexed

About

Heba Alkhatabi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Heba Alkhatabi has authored 43 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Heba Alkhatabi's work include Computational Drug Discovery Methods (6 papers), Acute Myeloid Leukemia Research (5 papers) and Epigenetics and DNA Methylation (5 papers). Heba Alkhatabi is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Acute Myeloid Leukemia Research (5 papers) and Epigenetics and DNA Methylation (5 papers). Heba Alkhatabi collaborates with scholars based in Saudi Arabia, United Kingdom and India. Heba Alkhatabi's co-authors include Walaa F. Alsanie, Ahmed Gaber, Raed I. Felimban, Majid Alhomrani, Abdulhakeem S. Alamri, Sonam Shakya, Moamen S. Refat, Hussain Alyami, Bassem M. Raafat and Hani A. Alhadrami and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Heba Alkhatabi

38 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba Alkhatabi Saudi Arabia 11 119 60 58 39 33 43 311
Teodora Pene Dumitrescu United States 11 318 2.7× 88 1.5× 55 0.9× 29 0.7× 35 1.1× 20 522
Álvaro Lorente‐Macías Spain 6 165 1.4× 45 0.8× 95 1.6× 41 1.1× 20 0.6× 15 345
Sandro Boland Belgium 9 197 1.7× 45 0.8× 54 0.9× 45 1.2× 33 1.0× 15 408
Yasemin Saygıdeğer Türkiye 14 203 1.7× 55 0.9× 114 2.0× 17 0.4× 32 1.0× 37 490
Daniel Kwon Canada 11 99 0.8× 94 1.6× 150 2.6× 35 0.9× 53 1.6× 16 537
Blake T. Riley Australia 11 194 1.6× 17 0.3× 16 0.3× 40 1.0× 38 1.2× 23 334
Pierrick Craveur France 14 413 3.5× 22 0.4× 34 0.6× 29 0.7× 15 0.5× 17 503
Rosario Recacha United States 11 227 1.9× 18 0.3× 93 1.6× 40 1.0× 51 1.5× 22 423
Thomas H. Marsilje United States 14 247 2.1× 46 0.8× 118 2.0× 26 0.7× 24 0.7× 21 433
Emeline Cros‐Perrial France 13 211 1.8× 27 0.5× 43 0.7× 13 0.3× 27 0.8× 33 371

Countries citing papers authored by Heba Alkhatabi

Since Specialization
Citations

This map shows the geographic impact of Heba Alkhatabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Alkhatabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Alkhatabi more than expected).

Fields of papers citing papers by Heba Alkhatabi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba Alkhatabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Alkhatabi. The network helps show where Heba Alkhatabi may publish in the future.

Co-authorship network of co-authors of Heba Alkhatabi

This figure shows the co-authorship network connecting the top 25 collaborators of Heba Alkhatabi. A scholar is included among the top collaborators of Heba Alkhatabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba Alkhatabi. Heba Alkhatabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Alkhatabi, Heba, et al.. (2024). In Silico Design of Peptide Inhibitors Targeting HER2 for Lung Cancer Therapy. Cancers. 16(23). 3979–3979. 2 indexed citations
4.
Alamri, Sultan H., et al.. (2024). Exosomal MicroRNAs in Alzheimer’s Disease: Unveiling Their Role and Pioneering Tools for Diagnosis and Treatment. Journal of Clinical Medicine. 13(22). 6960–6960. 7 indexed citations
5.
Hassan, Sabah M., Magdah Ganash, Mona G. Alharbi, et al.. (2023). Promoter Methylation-Regulated Differentially Expressed Genes in Breast Cancer. Breast Cancer Targets and Therapy. Volume 15. 435–450. 3 indexed citations
6.
Alsanie, Walaa F., Raed I. Felimban, Heba Alkhatabi, et al.. (2023). The Influence of Prenatal Exposure to Methamphetamine on the Development of Dopaminergic Neurons in the Ventral Midbrain. International Journal of Molecular Sciences. 24(6). 5668–5668. 3 indexed citations
7.
Alsanie, Walaa F., Majid Alhomrani, Ahmed Gaber, et al.. (2022). The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons. Cells. 11(5). 852–852. 4 indexed citations
8.
Alhomrani, Majid, Walaa F. Alsanie, Abdulhakeem S. Alamri, et al.. (2022). Enhancing the Antipsychotic Effect of Risperidone by Increasing Its Binding Affinity to Serotonin Receptor via Picric Acid: A Molecular Dynamics Simulation. Pharmaceuticals. 15(3). 285–285. 34 indexed citations
9.
Alharbi, Mona G., Magdah Ganash, Fatemah Basingab, et al.. (2022). DNA Methylation Level of Transcription Factor Binding Site in the Promoter Region of Acyl-CoA Synthetase Family Member 3 (ACSF3) in Saudi Autistic Children. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Alsanie, Walaa F., Abdulhakeem S. Alamri, Hussain Alyami, et al.. (2022). Increasing the Efficacy of Seproxetine as an Antidepressant Using Charge–Transfer Complexes. Molecules. 27(10). 3290–3290. 16 indexed citations
11.
Alsanie, Walaa F., Majid Alhomrani, Abdulhakeem S. Alamri, et al.. (2022). Attempting to Increase the Effectiveness of the Antidepressant Trazodone Hydrochloride Drug Using π-Acceptors. International Journal of Environmental Research and Public Health. 19(18). 11281–11281. 1 indexed citations
12.
13.
Alamri, Abdulhakeem S., Majid Alhomrani, Walaa F. Alsanie, et al.. (2022). Spectroscopic and Molecular Docking Analysis of π-Acceptor Complexes with the Drug Barbital. Applied Sciences. 12(19). 10130–10130. 10 indexed citations
14.
Alsanie, Walaa F., Majid Alhomrani, Ahmed Gaber, et al.. (2022). The Influence of Prenatal Exposure to Quetiapine Fumarate on the Development of Dopaminergic Neurons in the Ventral Midbrain of Mouse Embryos. International Journal of Molecular Sciences. 23(20). 12352–12352. 1 indexed citations
15.
Alsanie, Walaa F., Majid Alhomrani, Ahmed Gaber, et al.. (2022). Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons. Frontiers in Pharmacology. 13. 923113–923113. 6 indexed citations
16.
Alhadrami, Hani A., Ahmed M. Sayed, Heba Alkhatabi, Nabil A. Alhakamy, & Mostafa E. Rateb. (2021). Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor. Pharmaceuticals. 14(6). 541–541. 20 indexed citations
17.
Alhadrami, Hani A., Heba Alkhatabi, Fahad H. Abduljabbar, Usama Ramadan Abdelmohsen, & Ahmed M. Sayed. (2021). Anticancer Potential of Green Synthesized Silver Nanoparticles of the Soft Coral Cladiella pachyclados Supported by Network Pharmacology and In Silico Analyses. Pharmaceutics. 13(11). 1846–1846. 11 indexed citations
18.
Zaidi, Syed Kashif, et al.. (2021). Nebulization of Low-Dose S-Nitrosoglutathione in Diabetic Stroke Enhances Benefits of Reperfusion and Prevents Post-Thrombolysis Hemorrhage. Biomolecules. 11(11). 1587–1587. 3 indexed citations
19.
Alkhatabi, Heba, Thoraia Shinawi, Raed Alserihi, et al.. (2021). Investigation of Isocitrate Dehydrogenase 1 and 2 Mutations in Acute Leukemia Patients in Saudi Arabia. Genes. 12(12). 1963–1963. 2 indexed citations
20.
Alkhatabi, Heba, et al.. (2021). Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia. Virology. 560. 1–7. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teodora Pene Dumitrescu Breakdown of academic impact, for papers by Álvaro Lorente‐Macías Breakdown of academic impact, for papers by Sandro Boland Breakdown of academic impact, for papers by Yasemin Saygıdeğer Breakdown of academic impact, for papers by Daniel Kwon Breakdown of academic impact, for papers by Blake T. Riley Breakdown of academic impact, for papers by Pierrick Craveur Breakdown of academic impact, for papers by Rosario Recacha Breakdown of academic impact, for papers by Thomas H. Marsilje Breakdown of academic impact, for papers by Emeline Cros‐Perrial
Rankless by CCL
2026